Front page
Gene therapy
History
Concepts
Vocabulary
Lectures
Geenidoping
Patients
Q&A
On markets
Clinics
Diseases
Head- & neck cancer
Glioma
Macular degeneration
Vascular gene therapy
Chronic diseases
Science
Vectors
Treatment genes
Imaging
Reporter genes
Links
Contact info
PDF Print E-mail

Already on markets

SiBiono GeneTech: Gendicine®, China

Shanghai Sunway Biotech: Oncorine®, China

Ark Therapeutics: Cerepro®, Ranska (named patients)

 

Near markets


In EU and USA there are a few product entering the markets:

Ark Therapeutics (Anglo-Finnish company). The main product is a adenovirus-based Cerepro® (Sitimagene ceradenovec) for treatment of malignant glioma. In addition, the company has an adenovirus based Trinam®.


< Prev   Next >